<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02220127</url>
  </required_header>
  <id_info>
    <org_study_id>14/0050</org_study_id>
    <secondary_id>14/LO/0791</secondary_id>
    <secondary_id>145268</secondary_id>
    <nct_id>NCT02220127</nct_id>
  </id_info>
  <brief_title>RCT of the 4mm vs. the 8mm Collimator for GKR of Brain Micrometastases</brief_title>
  <official_title>Optimal Radiation Method for Gamma Knife Radiosurgery of Brain Micrometastases: A Multi-centre Randomised Clinical Trial (RCT) of the 4mm vs. the 8mm Collimator.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University College London Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College, London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gamma Knife Radiosurgery (GKR) is a well-established treatment modality for brain metastasis
      (Chiou 2013; Salvetti, Nagaraja et al. 2013). Large multicentre series have been published on
      patients with single and multiple cerebral metastases, treated with GKR over a period of 30
      years (Karlsson, Hanssens et al. 2009). Multiple institutions have reported a consistently
      high local tumour control rate of 80%-90% following GKR (Chang, Lee et al. 2000; Da Silva,
      Nagayama et al. 2009; Salvetti, Nagaraja et al. 2013).

      There is controversy over the use of GKR and/or Whole Brain Radiotherapy (WBRT) in patients
      with multiple metastases. WBRT provides a lower rate of distant recurrences, whereas GKR
      achieves good local control of treated lesions without the deleterious side effects of
      radiotherapy (Lippitz, Lindquist et al. 2014). This discussion is mainly focused on the risk
      of distant recurrences, which is lower if WBRT is given. There is evidence showing that
      Radiosurgery (RS) based on high contrast/resolution stereotactic MRI decreases the incidence
      and lengthens the time to distant recurrences (Hanssens, Karlsson et al. 2011). As a result,
      the current tendency is to treat all the lesions visible in high contrast/resolution images
      the day of Gamma Knife; which is followed by regular MRI follow ups and subsequent GKR for
      distant recurrences in order to avoid/delay WBRT.

      It has been estimated that more than a half of distant recurrences will grow from tumour
      cells that were already in the brain (as micrometastases) when radiosurgery is delivered, but
      not much has been studied on the optimal prescription and radiation delivery method for these
      lesions. There is controversy over which collimator should be used when treating
      micro-metastases (BmM). These lesions can either be treated with the 4mm collimator at an
      isodose between the 40% and 90%, or the 8mm collimator at an isodose above 90%. The 8 mm
      collimator is thought to offer better Local Control Rate (LCR) with the advantage of faster
      delivered treatments, while the 4 mm collimator is considered to be safer, given its steep
      dose fall-off. It is the aim of this study to find out which of the 4 mm or 8 mm collimators
      can achieve the higher LCR with less complications. A large number of lesions will be
      randomised to either the 4 or the 8 mm collimator and the patients followed up to evaluate
      clinical efficacy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Local control rate (LCR)</measure>
    <time_frame>up to 24 months after treatment</time_frame>
    <description>LCR will be evaluated through volumetric assessment of the lesion the day of Gamma Knife and in subsequent follow up MRI scans</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse radiation effects (ARE)</measure>
    <time_frame>up to two years</time_frame>
    <description>The following radiological and clinical outcomes will be used to assess ARE:
Bleeding from randomised lesions, Perilesional radiation induced necrosis, Severe peri-lesional oedema, New onset or worsened neurological deficit attributable to a randomised lesion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">298</enrollment>
  <condition>Brain Micrometastases</condition>
  <arm_group>
    <arm_group_label>8 mm collimator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>GKR with a single shot of the 8 mm collimator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 mm collimator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>GKR with a single shot of the 4 mm collimator</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>GKR with a single shot of the 8 mm collimator</intervention_name>
    <description>Gamma Knife Radiosurgery (GKR) with a single shot of the 8 mm collimator at an isodose above 90%.</description>
    <arm_group_label>8 mm collimator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>GKR with a single shot of the 4 mm collimator</intervention_name>
    <description>Gamma Knife Radiosurgery (GKR) with a single shot of the 4 mm collimator at an isodose between the 40% and 90%.</description>
    <arm_group_label>4 mm collimator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with brain metastasis from any primary tumour receiving GKR.

          -  All intracranial micro-metastases including lesions located in the cerebral
             hemispheres, thalamus, basal ganglia and cerebellum and excluding lesions located in
             the brain stem below the level of the superior colliculi.

          -  Target volume &lt; 0.14 cc3 and maximum diameter &lt; 7 mm.

          -  The subject consents to participate in the study.

        Exclusion Criteria:

          -  Inability to consent

          -  Younger than 18 years of age.

          -  Lesions in the brainstem (below the level of the superior colliculi) are better
             treated with the 4 mm collimator and they will be excluded from the study.

          -  Patients with more than 25 brain lesions suitable for randomisation will be excluded
             from the study.

          -  Co-morbidity or previous treatment such as surgery, chemotherapy or WBRT is not to be
             considered as exclusion criteria.

          -  Pregnancy in the context of brain metastases is not a contraindication for GKR, and
             therefore it will not be considered as exclusion criteria for this trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil Kitchen, Mr</last_name>
    <role>Study Chair</role>
    <affiliation>The National Hospital for Neurology and Neurosurgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alvaro Villabona, Dr</last_name>
    <phone>+44 020 3448 4076</phone>
    <email>a.villabona.11@ucl.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gamma Knife Centre at BUPA Cromwell Hospital</name>
      <address>
        <city>London</city>
        <zip>SW5 0TU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bodo Lippitz, MD</last_name>
      <phone>020 7460 5938</phone>
      <email>bodo.lippitz@cromwellhospital.com</email>
    </contact>
    <investigator>
      <last_name>Bodo Lippitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christer Lindquist, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Gamma Knife Centre at Queen Square</name>
      <address>
        <city>London</city>
        <zip>WC1N 3BG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alvaro Villabona, Dr</last_name>
      <phone>+44 020 3448 4076</phone>
      <email>a.villabona.11@ucl.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Ian Paddick, MSc,MIPM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Naomi Fersht, PhD, FRCR</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rolf JÃ¤ger, MD, FRCR</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katherine Miszkiel, MRCP, FRCR</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alvaro Villabona, MBBS, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Neil Kitchen, MD, FRCS(SN)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BMI Thornbury Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S10 3BR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andras Kemeny, FRCS, MD</last_name>
      <phone>01142674651</phone>
      <email>aakemeny@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Andras Kemeny, FRCS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Radatz, FRCS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeremy Rowe, FRCS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2014</study_first_submitted>
  <study_first_submitted_qc>August 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2014</study_first_posted>
  <last_update_submitted>March 19, 2015</last_update_submitted>
  <last_update_submitted_qc>March 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Brain</keyword>
  <keyword>Neoplasm Micrometastasis</keyword>
  <keyword>Gamma Knife Radiosurgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Micrometastasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

